Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
Section snippets
Acknowledgements
This work was supported by the Swedish Medical Research Council (5095, 7484), Åhlén-stiftelsen, Stiftelsen Elsa Goljes minne, Pfannenstills stiftelse, Fredrik och Ingrid Thurings stiftelse, Syskonen Svenssons fond för medicinsk forskning, Söderström-König Foundation, Research Foundation of the University Hospital in Linköping and the Karolinska Institute.
References (20)
- et al.
Network interactions in schizophrenia - therapeutic implications
Brain. Res. Rev.
(2000) Phencyclidine and the midbrain dopamine system: electrophysiology and behavior
Neurotoxicol. Teratol.
(1994)Phasic versus tonic dopamine release and the modulation of dopamine systems responsivity: a hypothesis for the etiology of schizophrenia
Neuroscience
(1991)- et al.
Age-related changes in kynurenic acid production in rat brain
Brain Res.
(1992) - et al.
Quantification of kynurenic acid in cerebrospinal fluid: effects of systemic and central L-kynurenine administration
J. Chromatogr.
(1990) - et al.
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
Neuropsychopharmacology
(1999) - et al.
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
Neurosci. Lett.
(1980) - et al.
Identification and quantification of kynurenic acid in human brain tissue
Brain Res.
(1988) - et al.
From the cover: increased baseline occupancy of D2 receptors by dopamine in schizophrenia
Proc. Natl. Acad. Sci.
(2000) - et al.
Chronic haloperidol administration decreases kynurenic acid levels in rat brain
Soc. Neurosci. Abstr.
(1999)
There are more references available in the full text version of this article.
Cited by (394)
Tryptophan metabolism in health and disease
2023, Cell MetabolismKynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder
2023, Brain, Behavior, and Immunity - HealthBinge-like mephedrone treatment induces memory impairment concomitant with brain kynurenic acid reduction in mice
2022, Toxicology and Applied Pharmacology
Copyright © 2001 Elsevier Science Ireland Ltd. All rights reserved.